Join BOPA
Back to news articles

Abstract Submission for #BOPA2025 is NOW OPEN

By BOPA on 31st March 2025

Abstract Submission for the 28th Annual BOPA Conference 2025 is now OPEN

 

Delegates are invited to present results of their clinical and technical work as a poster with some selected as an oral presentation. The author/s should submit via the BOPA website by midnight on Monday 23rd June. Abstracts will be reviewed and marked by the BOPA Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

 

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal.

 

Prizes:

• 1st Prize Oral Plenary: £1500 (to attend an international conference or pay towards research funding including open access publishing fees).
• 2nd Prize Oral Plenary: £500.

• All Oral Plenary presenters: free registration for BOPA 2026.
• All “Highly Recommended” presenters: free BOPA membership for 2026.
• The three best poster winners: free BOPA membership for 2026.

 

Click here for Call for Abstracts printable PDF

Click here for Abstract Marking Scheme as printable PDF 

 

Click here to go to the Abstract Submission Page

 

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article